Skip to content

A clinical trial to compare the effect of Individualized homoeopathic medicines as compared to placebo in patients with early haemorrhoids

A Double-Blind, Randomized, Placebo-Controlled Trial of Individualized Homoeopathy for the treatment of Early Haemorrhoidal Disease - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068980
Enrollment
208
Registered
2024-06-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K640- First degree hemorrhoids Health Condition 2: K641- Second degree hemorrhoids

Interventions

Intervention1: Sulphur, Nux Vomica, Lycopodium, Aesculus-hipp, Aloes-socotrina, Arsenic album, Graphites, Calcarea carb, Haemamelis, Pulsatilla, Natrum-muriaticum, Nitric Acid, Causticum, Collinsonia,

Sponsors

Central Council for Research in Homoeopathy, Ministry of AYUSH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from idiopathic/ primary grade I and grade II hemorrhoids presenting with any of the symptoms namely bleeding, pain (tenesmus), heaviness, pruritis, and mucus discharge with or without anitis. 2. Patients with known but controlled diabetes (glycated hemoglobin less than 8 %) and controlled hypertension and thyroid disorders will also be eligible for the study. 3. Patients using topical agents for hemorrhoids will be included after a washout period of one week, subject to persistence of symptoms and signs of hemorrhoids.

Exclusion criteria

Exclusion criteria: 1. Grade III and IV piles, anal fissure and fistula. 2. Patients with uncontrolled diabetes, hypertension and thyroid disorders. 3. Known case of hereditary piles, inflammatory bowel disease, enlarged prostate, chronic alcoholism, cirrhotic liver disease, recreational drug abuse, coagulation disorders, external hemorrhoids, previous history of surgery for hemorrhoids, hypertrophic anal papillae, rectal malignancies, history of leukemic disorders, patients with obstruction of portal circulation, pregnancy leading to obstruction of the portal circulation, lactating mothers, patients with psychiatric diseases. 4. Patients of Hemorrhoids with symptomatology of other than predefined drugs.

Design outcomes

Primary

MeasureTime frame
Hemorrhoidal Disease Symptom Score (HDSS)Timepoint: At the end of 1 month of treatment; 2 month of treatment; 3 month of treatment; 4 month of treatment; 5 month of treatment; 6 month of treatment

Secondary

MeasureTime frame
Anoscopic scoreTimepoint: At the end of 3 month of treatment and 6 month of treatment;Short Health Scale HD (SHSHD)Timepoint: At the end of 1 month of treatment; 2 month of treatment; 3 month of treatment; 4 month of treatment; 5 month of treatment; 6 month of treatment

Countries

India

Contacts

Public ContactPooja Gautam

Homoeopathic Treatment Center, Lady Hardinge Medical College

dr.poojagautam@gmail.com9868534738

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026